Abstract
Hypertension is one of the most common diseases in the general population. Despite the new generation of antihypertensive drugs and improved guidelines, there is still a poor number of patients with well-controlled hypertension. The particular group is patients with resistant hypertension. It is highly prevalent in the general hypertensive population and good control of those patients remains a great challenge. Renal sympathetic hyperactivity is a response mechanism of resistant hypertension. One of the options for those patients is transcatheter renal sympathetic denervation. Recent studies show promising results and it has become a possible therapeutic alternative to treat this group of patients.
Publisher
Centre for Evaluation in Education and Science (CEON/CEES)